Pharmacokinetic/LDL‐C and exposure–response analysis of tafolecimab in Chinese hypercholesterolemia patients: Results from phase I, II, and III studies
Yan, Shuling, Zhao, Xia, Xie, Qiushi, Du, Weijuan, Ma, Qingyang, Zhu, Tongkang, Deng, Huan, Qian, Lei, Zheng, Shirui, Cui, Yimin
Published in Clinical and translational science (01.12.2023)
Published in Clinical and translational science (01.12.2023)
Get full text
Journal Article